241 related articles for article (PubMed ID: 32184905)
21. Identification of the key genes and pathways involved in the tumorigenesis and prognosis of kidney renal clear cell carcinoma.
Cui H; Shan H; Miao MZ; Jiang Z; Meng Y; Chen R; Zhang L; Liu Y
Sci Rep; 2020 Mar; 10(1):4271. PubMed ID: 32144299
[TBL] [Abstract][Full Text] [Related]
22. A five-gene signature may predict sunitinib sensitivity and serve as prognostic biomarkers for renal cell carcinoma.
Chen YL; Ge GJ; Qi C; Wang H; Wang HL; Li LY; Li GH; Xia LQ
J Cell Physiol; 2018 Oct; 233(10):6649-6660. PubMed ID: 29327492
[TBL] [Abstract][Full Text] [Related]
23. Construction of exosome-related genes risk model in kidney cell carcinoma predicts prognosis and immune therapy response.
Gao C; Huang W; Su Q; Li J; Wang W; Qi Y; Du E; Zhang Z
Aging (Albany NY); 2024 May; 16(9):7622-7646. PubMed ID: 38728235
[TBL] [Abstract][Full Text] [Related]
24. Unique protein expression signatures of survival time in kidney renal clear cell carcinoma through a pan-cancer screening.
Han G; Zhao W; Song X; Kwok-Shing Ng P; Karam JA; Jonasch E; Mills GB; Zhao Z; Ding Z; Jia P
BMC Genomics; 2017 Oct; 18(Suppl 6):678. PubMed ID: 28984208
[TBL] [Abstract][Full Text] [Related]
25. A Novel Prognostic Predictor of Immune Microenvironment and Therapeutic Response in Kidney Renal Clear Cell Carcinoma based on Necroptosis-related Gene Signature.
Chen W; Lin W; Wu L; Xu A; Liu C; Huang P
Int J Med Sci; 2022; 19(2):377-392. PubMed ID: 35165523
[No Abstract] [Full Text] [Related]
26. Comprehensive analysis on the expression levels and prognostic values of LOX family genes in kidney renal clear cell carcinoma.
Lin S; Zheng L; Lu Y; Xia Q; Zhou P; Liu Z
Cancer Med; 2020 Nov; 9(22):8624-8638. PubMed ID: 32970930
[TBL] [Abstract][Full Text] [Related]
27. A promising Prognostic risk model for advanced renal cell carcinoma (RCC) with immune-related genes.
Cao P; Wu JY; Zhang JD; Sun ZJ; Zheng X; Yu BZ; Cao HY; Zhang FL; Gao ZH; Wang W
BMC Cancer; 2022 Jun; 22(1):691. PubMed ID: 35739510
[TBL] [Abstract][Full Text] [Related]
28. Identification and validation of a cigarette smoke-related five-gene signature as a prognostic biomarker in kidney renal clear cell carcinoma.
Huang Y; Wang Q; Tang Y; Liu Z; Sun G; Lu Z; Chen Y
Sci Rep; 2022 Feb; 12(1):2189. PubMed ID: 35140327
[TBL] [Abstract][Full Text] [Related]
29. Prognostic risk signature based on the expression of three m6A RNA methylation regulatory genes in kidney renal papillary cell carcinoma.
Sun Z; Jing C; Xiao C; Li T; Wang Y
Aging (Albany NY); 2020 Nov; 12(21):22078-22094. PubMed ID: 33177247
[TBL] [Abstract][Full Text] [Related]
30. Prognostic significance of promoter CpG island methylation of obesity-related genes in patients with nonmetastatic renal cell carcinoma.
Mendoza-Pérez J; Gu J; Herrera LA; Tannir NM; Zhang S; Matin S; Karam JA; Wood CG; Wu X
Cancer; 2017 Sep; 123(18):3617-3627. PubMed ID: 28543182
[TBL] [Abstract][Full Text] [Related]
31. Identification and Validation of Two Novel Prognostic lncRNAs in Kidney Renal Clear Cell Carcinoma.
Song J; Peng J; Zhu C; Bai G; Liu Y; Zhu J; Liu J
Cell Physiol Biochem; 2018; 48(6):2549-2562. PubMed ID: 30121668
[TBL] [Abstract][Full Text] [Related]
32. MicroRNA-15a tissue expression is a prognostic marker for survival in patients with clear cell renal cell carcinoma.
Mytsyk Y; Borys Y; Tumanovska L; Stroy D; Kucher A; Gazdikova K; Rodrigo L; Kruzliak P; Prosecky R; Urdzik P; Dosenko V
Clin Exp Med; 2019 Nov; 19(4):515-524. PubMed ID: 31440867
[TBL] [Abstract][Full Text] [Related]
33. Construction of immune-related risk signature for renal papillary cell carcinoma.
Wang Z; Song Q; Yang Z; Chen J; Shang J; Ju W
Cancer Med; 2019 Jan; 8(1):289-304. PubMed ID: 30516029
[TBL] [Abstract][Full Text] [Related]
34. A five-gene signature predicts overall survival of patients with papillary renal cell carcinoma.
Gao Z; Zhang D; Duan Y; Yan L; Fan Y; Fang Z; Liu Z
PLoS One; 2019; 14(3):e0211491. PubMed ID: 30822312
[TBL] [Abstract][Full Text] [Related]
35. Comprehensive analysis of a novel lncRNA profile reveals potential prognostic biomarkers in clear cell renal cell carcinoma.
Liu T; Sui J; Zhang Y; Zhang XM; Wu WJ; Yang S; Xu SY; Hong WW; Peng H; Yin LH; Pu YP; Liang GY
Oncol Rep; 2018 Sep; 40(3):1503-1514. PubMed ID: 30015930
[TBL] [Abstract][Full Text] [Related]
36. Glutathione peroxidase family and survival prognosis in patients with renal cell carcinoma.
Li J; Huo S; Zhang R; Shi C; Sun N; Liu Q
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2022 May; 47(5):562-572. PubMed ID: 35753726
[TBL] [Abstract][Full Text] [Related]
37.
Lin TC
Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32326089
[TBL] [Abstract][Full Text] [Related]
38. Identification of miRNA signatures for kidney renal clear cell carcinoma using the tensor-decomposition method.
Ng KL; Taguchi YH
Sci Rep; 2020 Sep; 10(1):15149. PubMed ID: 32938959
[TBL] [Abstract][Full Text] [Related]
39. microRNA‑572 functions as an oncogene and a potential biomarker for renal cell carcinoma prognosis.
Pan X; Li Z; Zhao L; Quan J; Zhou L; Xu J; Xu W; Guan X; Li H; Yang S; Gui Y; Lai Y
Oncol Rep; 2018 Nov; 40(5):3092-3101. PubMed ID: 30132566
[TBL] [Abstract][Full Text] [Related]
40. Prognostic and therapeutic implications of extracellular matrix associated gene signature in renal clear cell carcinoma.
Ahluwalia P; Ahluwalia M; Mondal AK; Sahajpal N; Kota V; Rojiani MV; Rojiani AM; Kolhe R
Sci Rep; 2021 Apr; 11(1):7561. PubMed ID: 33828127
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
